Bioceramics Market Size was valued at USD 12.30 Billion in 2023. The Bioceramics industry is projected to grow from USD 13.54 Billion in 2024 to USD 26.60 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.80% during the forecast period (2024 - 2032). Increasing healthcare expenditure and increased demand for innovative medical devices are the key market drivers enhancing market growth.Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for bioceramics is biocompatible ceramic materials used in medical applications such as dental implants, bone substitutes, and joint replacements. A prominent driver of the bioceramics market is the increasing demand for bioceramics in medical applications. The rising frequency of chronic ailments such as osteoporosis, arthritis, and dental problems is boosting demand for bioceramics in medical applications. Bioceramics are extremely biocompatible and can be utilized in a variety of medical operations without generating any negative side effects in the body. Furthermore, bioceramics have outstanding mechanical features such as high strength, durability, and wear resistance, making them ideal for use in medical implants.
Furthermore, the increased emphasis on research and development operations to produce new bioceramic materials with improved features is propelling the bioceramics market forward. For example, scientists are investigating the use of bioceramics in tissue engineering applications to create artificial organs and tissues.
Another driver of the bioceramics market is the growing demand for bioceramics in orthopedic applications such as hip and knee replacements. Bioceramics are frequently employed in orthopedic applications because to their outstanding mechanical qualities, biocompatibility, and ability to connect with bone tissue.
For instance, due to its great strength, wear resistance, and biocompatibility, zirconia-toughened alumina (ZTA) bioceramics are frequently employed in hip and knee replacements. ZTA bioceramics have a low friction coefficient, which helps to reduce wear and tear on the implant, resulting in a longer implant life.
In addition, the growing number of people suffering from orthopedic illnesses including osteoarthritis and osteoporosis is pushing demand for bioceramics in orthopedic applications. Osteoarthritis is the most common joint ailment, affecting more than 10% of men and 18% of women over the age of 60, according to the World Health Organization.
The growing medical sector in developing countries, as well as the use of these ceramics in electronic devices, has been identified as key growth drivers in the bio-ceramics and piezoceramics markets. Because of an aging population, certain emerging countries are seeing an increase in osteoarthritis. To solve this issue, these ceramics are used in hip replacement and knee implants. Ceramics have high tensile and compressive strength, which makes them ideal for use as implants. Furthermore, there is an increasing need for these ceramics in the production of healthcare devices including as hearing aids, artificial joints, and cardiovascular device components.
According to the World Health Organization, oral problems represent a significant health burden for many nations, affecting nearly 3.5 billion people. Examples include dental caries, oro-dental trauma, oral cancer, and periodontal (gum) disease. As a result, spending on dental treatment has skyrocketed.
Bioceramics in dental applications is a growing segment. As the number of people suffering from chronic diseases increases, the demand for bioceramics will also increase. In addition to this, the growing number of dental procedures will drive growth of the market. It includes tooth fillings, pulp capping, and alveolar ridge augmentation. Increasing demand for new and advanced products is expected to propel growth of market.
April 2023: FKG Dentaire added new bioceramic products, BC Universal RRM and BC Universal Sealer, to its endodontic obturation portfolio across the European Union (EU), Israel, and the United Kingdom.
The Bioceramics Market segmentation, based on Material includes Aluminum Oxide, Zirconia, Calcium Phosphate And Others. During the projection period, zirconia is expected to dominate the market. Zirconia, a highly sought-after bioinert ceramic substance, is expected to increase rapidly. Furthermore, it is employed in the production of ceramic-based crowns, bridges, and other implant devices. Similarly, hydroxyapatite on cellulose fibres is used to reinforce dental restorations.
The Bioceramics Market segmentation, based on Application, includes Orthopedic, Dental Implants, Biomedical and Others. Bioceramics demand in dental implants category is the fastest growing segment inf the market in 2022, making it the second most important category after orthopedics. Because ceramic-based crowns and bridges have tints that closely resemble the original teeth crowns, the dental implants sector is likely to be a key market driver.
Figure1: Bioceramics Market, by Application, 2022&2032 (USD Billion)Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America is the market leader in bioceramics, due to the presence of a large number of bioceramics manufacturers, high acceptance of bioceramics in the healthcare industry, and increasing demand for bioceramics in dentistry and orthopedic applications. In addition, the area is home to several major medical device businesses that are propelling the bioceramics market forward through product research and development.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure2: BIOCERAMICS MARKET SHARE BY REGION 2022 (USD Billion) Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Bioceramics Market accounts for the second-largest market share due to rising demand for ceramic-based restorations is likely to drive market growth. Further, the German Bioceramics Market held the largest market share, and the UK Bioceramics Market was the fastest growing market in the European region
The Asia-Pacific Bioceramics Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to increasing healthcare cost, rising elderly population, and growing need for innovative medical devices. Moreover, China’s Bioceramics Market held the largest market share, and the Indian Bioceramics Market was the fastest growing market in the Asia-Pacific region.
Germany-based independent private equity firm SHS Gesellschaft, fur Beteiligungsmanagement mbH, bought an undisclosed majority stake in CAM Bioceramics in July 2023. This acquisition is intended to strengthen SHS's standing within biomedical calcium phosphate solutions; it also represents a significant step forward for the company’s growth strategy in this area of expertise.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Bioceramics Market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Bioceramics industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Bioceramics industry to benefit clients and increase the market sector. In recent years, the Bioceramics industry has offered some of the most significant advantages to medicine. Major players in the Bioceramics Market, including CeramTec GmbH, Kyocera Corporation, Zimmer-Biomet Holdings Inc., HC Starck GmbH, Saint-Gobain Ceramics & Plastics Inc., and NGK Spark Plug Co. Ltd. and others, are attempting to increase market demand by investing in research and development operations.
Straumann Group is a Swiss firm headquartered in Basel, Switzerland, that manufactures dental implants and specializes in associated technology. The company conducts research, develops, manufactures, and sells dental implants, instruments, biomaterials, CADCAM prostheses, digital equipment, software, and clear aligners for replacement, restorative, orthodontic, and preventative dentistry. The Straumann Group also provides training and instruction to the dental profession around the world in partnership with the International Team for Implantology (ITI) and the Instituto Latino Americano de Pesquisa e Ensino Odontológico (ILAPEO). Its products and services are offered in over 100 countries via a large network of distribution subsidiaries and partners. In 2020, Straumann, a renowned producer of dental implants, has announced the release of the Straumann® PURE Ceramic Implant, a novel bioceramic dental implant. The implant is constructed of a biocompatible high-performance ceramic material that provides great osseointegration. The implant is intended to provide patients with dental implants with a metal-free and aesthetically pleasing option.
3D Systems, based in Rock Hill, South Carolina, designs, manufactures, and sells 3D printers, 3D printing materials, 3D scanners, and a 3D printing service. The company develops product concept models, precision and functional prototypes, tooling master patterns, and production parts for direct digital manufacturing. It fabricates physical products utilizing proprietary techniques and input from computer-aided design and manufacturing software, as well as 3D scanning and sculpting technologies. 3D Systems' technologies and services are used in numerous industries, including aerospace, automotive, healthcare, dental, entertainment, and durable goods, during the design, development, and production stages. In 2019, 3D Systems announced the creation of bioceramic bone implants created in 3D using their Figure 4® 3D printing technology. The bioceramic implants are constructed of a unique bioceramic substance and are intended to enhance bone regeneration. When compared to typical metal implants, which can cause discomfort and agony, the implants are predicted to provide superior patient results.
Collagen Matrix Inc. Royal DSM
Nobel Biocare Services AG
Sagemax Bioceramics Inc
Carborundum Universal Ltd
CAM Bioceramics B.V.
Dentsply Sirona
DOCERAM Medical Ceramics GmbH
Amedica Corporation
March 2019, BONESUPPORTTM extends its distribution agreement with Zimmer Biomet for CERAMENTTM bone void filler in the United States.
November 2022, Tethon 3D, a ceramic 3D printer and material maker, has announced a collaboration with Fortify, a composite 3D printing start-up, to develop more technical ceramic materials for 3D printing. This collaboration will allow ceramic additive manufacturing to enter high-performance applications in industries such as aerospace, medicine, and energy.
June 2020, Amatec announced the availability of CAM Bioceramics' medical grade ceramic materials for use with Admaflex DLP 3D printing systems.
September 2023, Straumann Group purchased AlliedStar so as to fill some gaps in its intraoral scanner line and extend the reach of its digital solutions.Smith+Nephew launched the OR3O Dual Mobility System in India for both primary and revision hip arthroplasty in August 2023.
Bioceramics Market By Material Outlook
Aluminum Oxide
Zirconia
Calcium Phosphate
Others
Bioceramics Market By Application Outlook
Orthopedic
Dental Implants
Biomedical
Others
Bioceramics Regional Outlook
North America
Europe
Asia-Pacific
Rest of the World
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)